Bankier Alain D 4
4 · NEXIEN BIOPHARMA, INC. · Filed Oct 29, 2018
Insider Transaction Report
Form 4
Bankier Alain D
Director
Transactions
- Award
Stock options (right to buy)
2018-10-01+500,000→ 500,000 totalExercise: $0.48From: 2018-10-01Exp: 2025-10-01→ Common Stock (500,000 underlying) - Award
Stock options (right to buy)
2018-10-26+500,000→ 500,000 totalExercise: $0.66From: 2018-10-26Exp: 2025-10-26→ Common Stock (500,000 underlying)
Holdings
- 2,256,000
Common Stock
- 840,000
Stock options - right to buy
Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ Common Stock (840,000 underlying) - 100,000
Stock options (right to buy)
Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ Common Stock (100,000 underlying) - 28,000
Class D Warrants (right to buy)
Exercise: $1.00From: 2018-08-06Exp: 2018-11-30→ Units (28,000 underlying)
Footnotes (4)
- [F1]Granted under the Company's 2018 Equity Incentive Plan.
- [F2]70,000 options vested immediately, with the remainder vesting monthly over the next 11 months beginning August 1, 2018.
- [F3]25,000 options vested immediately, with the remainder vesting quarterly over the next 6 quarters beginning with the quarter ending September 30, 2018.
- [F4]Each unit consists of one share of common stock and one Class E Warrant.